File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: A framework for modeling radiation induced lymphopenia in radiotherapy

TitleA framework for modeling radiation induced lymphopenia in radiotherapy
Authors
KeywordsImmune organ at risk
Immune system
Lymphopenia
Radiation dose to the blood
Radiosensitivity
Issue Date1-Mar-2020
PublisherElsevier
Citation
Radiotherapy & Oncology, 2020, v. 144, p. 105-113 How to Cite?
Abstract

Introduction

Associations between radiation-induced lymphopenia (RIL) and survival have been extensively reported. However, the immune system is not considered as an organ-at-risk (OAR) in radiotherapy. This study aimed to develop the framework of an immune OAR model that may be utilized to predict and minimize RIL.

Methods

A dynamic model was first developed for lymphocyte trafficking among 5 compartments of the immune system. Radiation dose to the circulating lymphocytes in each compartment was calculated based on the doses to fixed structures of each immune compartment and blood flow patterns. A RIL model was developed based on lymphocyte dynamics, lymphocyte radiosensitivity and reproductivity, and the dose to the lymphocytes. The model was tested in 51 patients by fitting it to weekly-measured absolute lymphocyte counts (ALC) for each patient, considering lymphocyte radiosensitivity and reproductivity as patient-dependent fitting parameters.

Results

The fitting was almost perfect for 20 patients, with sum of square of errors (SSE) between measured and predicted ALCs < 0.5. It was acceptable for another 27 patients, with SSE = 0.5~4.0. Only 4 patients had SSE > 4.0. The fitting also provided a method of in vivo estimation of radiosensitivity (α) for each patient. The median α was 0.40 Gy−1 for the 51 patients, consistent with in vitro measured data of 0.41 Gy−1 in the literature.

Conclusion

We have presented a framework of developing an immune OAR model that has the potential to predict and minimize RIL in radiotherapy.


Persistent Identifierhttp://hdl.handle.net/10722/344095
ISSN
2023 Impact Factor: 4.9
2023 SCImago Journal Rankings: 1.702

 

DC FieldValueLanguage
dc.contributor.authorJin, Jian-Yue-
dc.contributor.authorMereniuk, Todd-
dc.contributor.authorYalamanchali, Anirudh-
dc.contributor.authorWang, Weili-
dc.contributor.authorMachtay, Mitchell-
dc.contributor.authorKong, FS-
dc.contributor.authorEllsworth, Susannah-
dc.date.accessioned2024-07-03T08:40:37Z-
dc.date.available2024-07-03T08:40:37Z-
dc.date.issued2020-03-01-
dc.identifier.citationRadiotherapy & Oncology, 2020, v. 144, p. 105-113-
dc.identifier.issn0167-8140-
dc.identifier.urihttp://hdl.handle.net/10722/344095-
dc.description.abstract<h3>Introduction</h3><p>Associations between radiation-induced lymphopenia (RIL) and survival have been extensively reported. However, the immune system is not considered as an organ-at-risk (OAR) in radiotherapy. This study aimed to develop the framework of an immune OAR model that may be utilized to predict and minimize RIL.</p><h3>Methods</h3><p>A dynamic model was first developed for lymphocyte trafficking among 5 compartments of the immune system. Radiation dose to the circulating lymphocytes in each compartment was calculated based on the doses to fixed structures of each immune compartment and blood flow patterns. A RIL model was developed based on lymphocyte dynamics, lymphocyte radiosensitivity and reproductivity, and the dose to the lymphocytes. The model was tested in 51 patients by fitting it to weekly-measured absolute lymphocyte counts (ALC) for each patient, considering lymphocyte radiosensitivity and reproductivity as patient-dependent fitting parameters.</p><h3>Results</h3><p>The fitting was almost perfect for 20 patients, with sum of square of errors (SSE) between measured and predicted ALCs < 0.5. It was acceptable for another 27 patients, with SSE = 0.5~4.0. Only 4 patients had SSE > 4.0. The fitting also provided a method of <em>in vivo</em> estimation of radiosensitivity (α) for each patient. The median α was 0.40 Gy<sup>−1</sup> for the 51 patients, consistent with <em>in vitro</em> measured data of 0.41 Gy<sup>−1</sup> in the literature.</p><h3>Conclusion</h3><p>We have presented a framework of developing an immune OAR model that has the potential to predict and minimize RIL in radiotherapy.</p>-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofRadiotherapy & Oncology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectImmune organ at risk-
dc.subjectImmune system-
dc.subjectLymphopenia-
dc.subjectRadiation dose to the blood-
dc.subjectRadiosensitivity-
dc.titleA framework for modeling radiation induced lymphopenia in radiotherapy-
dc.typeArticle-
dc.identifier.doi10.1016/j.radonc.2019.11.014-
dc.identifier.scopuseid_2-s2.0-85075763332-
dc.identifier.volume144-
dc.identifier.spage105-
dc.identifier.epage113-
dc.identifier.issnl0167-8140-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats